Fenbendazole is one of the most widely used dewormers in farm animals, given to cattle, sheep, goats, pigs and poultry to control intestinal worms. Because these animals become food, a natural question follows: how much of the drug, if any, ends up in the meat, milk or eggs on a family's table, and who decides how much is acceptable? This article explains what a maximum residue limit (MRL) is, what a withdrawal period is, how international and national regulators calculate both for fenbendazole, how compliance is checked, and where the real uncertainties lie. It also explains why these numbers say nothing about fenbendazole as a human medicine, which it is not.

What fenbendazole is and what happens to it in an animal

Fenbendazole belongs to the benzimidazole family of anthelmintics, developed in the 1970s. It works by binding to tubulin, the protein that builds microtubules, the internal scaffolding of cells. Worm tubulin binds the drug far more readily than mammalian tubulin, which is the basis of its selective toxicity and its wide safety margin in treated animals.

Once swallowed, fenbendazole is only partly absorbed. Much of the dose passes through the gut and is excreted in faeces. The absorbed portion is metabolised, largely in the liver, into two main compounds:

Because the parent drug and its metabolites interconvert and occur together, regulators do not measure fenbendazole alone. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) and the European Medicines Agency both define the marker residue as the sum of fenbendazole, oxfendazole and oxfendazole sulfone, expressed as oxfendazole sulfone equivalents. The liver consistently carries the highest residues, which is why liver limits are set higher than those for muscle or fat.

Step one: deciding how much is safe to eat every day

Every residue limit rests on a single number: the acceptable daily intake (ADI), the amount of a substance a person could consume daily over a lifetime without appreciable health risk. Regulators derive it from animal toxicology studies, in which laboratory animals receive a range of doses for weeks to years and are examined for any adverse effect. The highest dose producing no adverse effect (the no-observed-adverse-effect level) is then divided by a safety factor, typically 100: a factor of 10 for possible differences between animals and humans, and another 10 for variation among people, including the young, the elderly and the sick.

For fenbendazole, JECFA set a group ADI of 0 to 7 micrograms per kilogram of body weight, shared with oxfendazole and febantel (a related drug that converts to fenbendazole in the body). A group ADI reflects the sensible principle that a consumer's exposure to all three compounds should be counted together, not separately.

The toxicological endpoint of greatest concern for this drug class deserves plain mention. Some benzimidazoles, by disrupting microtubules during cell division, can cause chromosome mis-segregation (aneuploidy) and have shown embryotoxic or teratogenic effects in laboratory animals at sufficiently high doses; oxfendazole and albendazole are the clearest examples. Fenbendazole has generally appeared less embryotoxic in reproductive studies, but regulators assessed the whole group with these effects in view. Importantly, the aneuploidy mechanism is understood to have a threshold: below a certain concentration, tubulin binding is insufficient to disrupt cell division. That scientific judgement is what allows a safe intake to be set at all. Including reproductive and developmental studies in the assessment means the ADI is designed to protect the most vulnerable consumers, the child developing in the womb among them. A system of food safety that takes the unborn into account is one worth understanding and supporting.

Step two: turning a safe intake into a residue limit

An ADI tells you how much a person may safely consume; it does not tell a laboratory what concentration to allow in a kidney or a litre of milk. That translation is the job of the MRL, the highest legally permitted concentration of the marker residue in a given food.

Regulators work from a standardised, deliberately generous "food basket". JECFA's model diet assumes a person eats, every day, 300 grams of muscle, 100 grams of liver, 50 grams of kidney, 50 grams of fat and drinks 1.5 litres of milk. The European model is similar in scale. Few people eat liver and kidney daily, so the model overstates real exposure on purpose.

Residue depletion studies supply the other half of the calculation. Animals are dosed, often with a radiolabelled form of the drug that lets scientists trace every breakdown product, and then slaughtered at intervals so residues in each tissue can be measured over time. These studies reveal what fraction of total drug-related residue the marker represents, so the MRLs can be set such that total residues in the full food basket stay within the ADI.

Codex Alimentarius, the international food standards body, adopted fenbendazole MRLs based on JECFA's evaluation in the late 1990s for cattle, sheep, goats and pigs: 100 micrograms per kilogram in muscle, kidney and fat, 500 micrograms per kilogram in liver, and 100 micrograms per kilogram in milk. To put that in perspective, 100 micrograms per kilogram equals 0.1 parts per million. The European Union lists its own MRLs for the same marker residue, with lower values for several foods, milk included. The United States sets "tolerances" through the Food and Drug Administration, using its own marker residue definitions for each species and tissue. Different jurisdictions reach somewhat different numbers from different data sets, model diets and policy choices, but all are built on the same logic of a safe daily intake protected by conservative assumptions.

Step three: the withdrawal period

The MRL is the limit; the withdrawal period (also called withholding time or withdrawal time) is the practical instruction that ensures the limit is met. It is the minimum time that must pass between the last dose and the moment an animal may be slaughtered for food, or its milk or eggs sold.

Withdrawal periods are calculated from the same depletion studies, but with a statistical safeguard. Under European Medicines Agency guidance, the standard approach is to determine the time at which residues in the slowest-clearing tissue fall below the MRL in 95 percent of treated animals, with 95 percent statistical confidence. A margin is often added on top. Milk withdrawal is set by a parallel method, accounting for differences between high- and low-yielding cows.

Withdrawal periods are product-specific, not drug-specific. They depend on the species, the formulation (feed additive, oral suspension, paste, pellets), the dose and the route, and they differ between countries because the underlying MRLs differ. For fenbendazole, labelled meat withdrawal periods range from zero days for some feed products in some species up to more than a week for certain cattle and sheep products in some markets. Some fenbendazole products approved for lactating dairy cattle in the United States carry a zero-day milk discard at the labelled dose, while some products elsewhere require milk to be withheld for several days. The only reliable source is the label of the specific product used, in the country where it is used.

When products are used off-label, and how compliance is checked

A label's withdrawal period applies only when the drug is used exactly as labelled. If a veterinarian prescribes a higher dose, a longer course or use in an unlisted species, the residue data behind the label no longer apply. Regulators handle this differently:

Compliance is then verified independently. National residue surveillance programmes, such as the US Department of Agriculture's National Residue Program and the residue control plans required of every EU member state, sample carcasses, milk and eggs and test them for veterinary drug residues, benzimidazoles among them. Published results across many years have shown that the large majority of samples comply, with occasional violations traced back to individual farms, typically caused by missed withdrawal times or record-keeping errors rather than by the limits themselves. Violations trigger investigation and, where warranted, enforcement.

At root, this system depends on the conscientious farmer. Keeping accurate treatment records, reading labels, identifying treated animals and honouring withdrawal times are acts of stewardship toward animals, customers and neighbours alike. Regulation sets the boundaries; daily responsibility on the farm is what actually keeps residues out of the food supply.

What these limits do not mean

Fenbendazole has drawn public interest in recent years as a possible cancer treatment for people, driven largely by personal testimonials. It is worth being clear: fenbendazole is not approved for any human use by the FDA, the European Medicines Agency or any comparable regulator. Laboratory studies, including work published in Scientific Reports in 2018, have shown that it disrupts microtubules and can kill cancer cells in culture, and some mouse studies have reported effects on tumour growth. These are cell-culture and animal findings; no controlled human clinical trials have established its effectiveness or safety for cancer, and published case reports have described drug-induced liver injury in people who took it on their own.

The residue limits discussed here are sometimes misread in two opposite directions. They do not show that fenbendazole is harmless at any dose, and they do not show that eating meat from treated animals is risky. They establish a narrow point: that trace residues, at or below the MRL in a deliberately exaggerated diet, stay within an intake judged safe with a hundredfold margin. Anyone weighing fenbendazole as a personal treatment is weighing a very different question, at doses many thousands of times higher, and deserves a frank conversation with their own physician, who can help them understand the evidence and make an informed decision.

Key takeaway: Maximum residue limits for fenbendazole are calculated from animal toxicology, a hundredfold safety margin and a deliberately generous model diet, and withdrawal periods translate those limits into practical waiting times on the farm, so that consumers, including the unborn, are protected when farmers follow the label.